West Tower Group »

Vaneck Vectors Pharmaceutical etf shares owned by West Tower Group

Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by West Tower Group from 13F filings

Historical chart of West Tower Group investment in Vaneck Vectors Pharmaceutical etf

Tip: Access up to 7 years of quarterly data

All positions including Vaneck Vectors Pharmaceutical etf held by West Tower Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by West Tower Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $33k 409 81.37
2023-09-30 $34k 426 79.86

More positions owned by West Tower Group

Oxford Industries (OXM)
Keurig Dr Pepper (KDP)
Orion Engineered Carbons (OEC)
Warner Bros Discovery Com Ser A (WBD)
Enhabit Ord (EHAB)
Kohl's Corporation (KSS)
Macy's (M)
Onespaworld Holdings Ltd onespaworld hold (OSW)
Griffon Corporation (GFF)
Gms (GMS)
Tyler Technologies (TYL)
Dropbox Cl A (DBX)
Select Sector Spdr Tr Rl Est Sel Sec (XLRE)
Ferroglobe SHS (GSM)
Akoustis Technologies (AKTS)

View all positions for West Tower Group

Top funds holding Vaneck Vectors Pharmaceutical etf

Goldman Sachs Group
Bank of America Corporation
Healthcare Of Ontario Pension Plan Trust Fund
Avalon Trust
Jpmorgan Chase & Co
Miller Investment Management
Prime Capital Investment Advisors
Bnp Paribas Arbitrage, Snc
Independent Advisor Alliance
Phoenix Holdings
Citadel Advisors
Avestar Capital
Gladstone Institutional Advisory
Hrt Financial
Twelve Points Wealth Management

View all funds holding Vaneck Vectors Pharmaceutical etf